Transcriptome analysis of Escherichia coli O157: H7 grown invitro in the sterile-filtrated cecal content of human gut microbiota associated rats reveals an adaptive expression of metabolic and virulence genes

Microbes and Infection

Volumn 17, Issue 1, 2015, Pages 23-33

  Le Bihan, Guillaume ^a   Jubelin, Grégory ^b   Garneau, Philippe ^a   Bernalier Donadille, Annick ^b   Martin, Christine ^b   Beaudry, Francis ^a   Harel, Josée ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CEMAGREF   (France)

Author keywords

Enterohemorrhagic Escherichia coli; Intestinal milieu; Metabolism; Transcriptome; Virulence

Indexed keywords

CARBOHYDRATE; COMPLEMENTARY DNA; GLYCEROL; N ACETYLNEURAMINIC ACID; RNA; TRANSCRIPTOME; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CECUM; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; FECES ANALYSIS; GENE EXPRESSION; IN VITRO STUDY; INTESTINE FLORA; METABOLISM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; ADAPTATION; ADULT; ANIMAL; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MICROBIOLOGY; MICROFLORA; ORGANISMAL INTERACTION; PHYSIOLOGY;

ESCHERICHIA COLI; RATTUS;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; CECUM; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICROBIAL INTERACTIONS; MICROBIOTA; RATS; VIRULENCE FACTORS;

EID: 84921060300     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.09.008     Document Type: Article

References (50)

1. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
2. Tobe T., Beatson S.A., Taniguchi H., Abe H., Bailey C.M., Fivian A., et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 2006, 103:1494-1496.
3. Maltby R., Leatham-Jensen M.P., Gibson T., Cohen P.S., Conway T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS One 2013, 8:e53957.
4. Sekirov I., Finlay B.B. The role of the intestinal microbiota in enteric infection. J Physiol 2009, 587:4159-4167.
5. Kamada N., Kim Y.G., Sham H.P., Vallance B.A., Puente J.L., Martens E.C., et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
6. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
7. Bertin Y., Chaucheyras-Durand F., Robbe-Masselot C., Durand A., de la Foye A., Harel J., et al. Carbohydrate utilization by enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. Environ Microbiol 2013, 15:610-622.
8. Bertin Y., Girardeau J.P., Chaucheyras-Durand F., Lyan B., Pujos-Guillot E., Harel J., et al. Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. Environ Microbiol 2011, 13:365-377.
9. Miranda R.L., Conway T., Leatham M.P., Chang D.E., Norris W.E., Allen J.H., et al. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect Immun 2004, 72:1666-1676.
10. Barnett Foster D. Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence 2013, 4:315-323.
11. Hernandez-Doria J.D., Sperandio V. Nutrient and chemical sensing by intestinal pathogens. Microbes Infect 2013, 15:759-764.
12. Matsumoto M., Kibe R., Ooga T., Aiba Y., Kurihara S., Sawaki E., et al. Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep 2012, 2:233.
13. Alpert C., Sczesny S., Gruhl B., Blaut M. Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol 2008, 10:17-24.
14. de Sablet T., Chassard C., Bernalier-Donadille A., Vareille M., Gobert A.P., Martin C. Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 2009, 77:783-790.
15. Crouzet L., Gaultier E., Del'Homme C., Cartier C., Delmas E., Dapoigny M., et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 2013, 25:e272-e282.
16. Dostal A., Lacroix C., Pham V.T., Zimmermann M.B., Del'homme C., Bernalier-Donadille A., et al. Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats. Br J Nutr 2014, 111:2135-2145.
17. Riley L.W., Remis R.S., Helgerson S.D., McGee H.B., Wells J.G., Davis B.R., et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983, 308:681-685.
18. Chekabab S.M., Jubelin G., Dozois C.M., Harel J. PhoB activates Escherichia coli O157:H7 virulence factors in response to inorganic phosphate limitation. PLoS One 2014, 9:e94285.
19. Blazejczyk M.M.M., Robert N. FlexArray: a statistical data analysis software for gene expression microarrays 2007, http://genomequebec.mcgill.ca/FlexArray/.
20. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
21. Branchu P., Matrat S., Vareille M., Garrivier A., Durand A., Crepin S., et al. NsrR, GadE, and GadX interplay in repressing expression of the Escherichia coli O157:H7 LEE pathogenicity island in response to nitric oxide. PLoS Pathog 2014, 10:e1003874.
22. Davidsen T., Beck E., Ganapathy A., Montgomery R., Zafar N., Yang Q., et al. The comprehensive microbial resource. Nucleic Acids Res 2010, 38:D340-D345.
23. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
24. Bertin Y., Deval C., de la Foye A., Masson L., Gannon V., Harel J., et al. The gluconeogenesis pathway is involved in maintenance of enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. PLoS One 2014, 9:e98367.
25. Robbe C., Capon C., Coddeville B., Michalski J.C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 2004, 384:307-316.
26. Bustamante V.H., Santana F.J., Calva E., Puente J.L. Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression. Mol Microbiol 2001, 39:664-678.
27. Kailasan Vanaja S., Bergholz T.M., Whittam T.S. Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol 2009, 191:1868-1877.
28. Tree J.J., Roe A.J., Flockhart A., McAteer S.P., Xu X., Shaw D., et al. Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol 2011, 80:1349-1365.
29. Hansen A.M., Kaper J.B. Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol 2009, 73:446-465.
30. Njoroge J.W., Nguyen Y., Curtis M.M., Moreira C.G., Sperandio V. Virulence meets metabolism: Cra and KdpE gene regulation in enterohemorrhagic Escherichia coli. MBio 2012, 3:e00280-12.
31. Nakanishi N., Tashiro K., Kuhara S., Hayashi T., Sugimoto N., Tobe T. Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology 2009, 155:521-530.
32. Lloyd S.J., Ritchie J.M., Torres A.G. Fimbriation and curliation in Escherichia coli O157:H7: a paradigm of intestinal and environmental colonization. Gut Microbes 2012, 3:272-276.
33. Menestrina G., Moser C., Pellet S., Welch R. Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology 1994, 87:249-267.
34. Samadder P., Xicohtencatl-Cortes J., Saldana Z., Jordan D., Tarr P.I., Kaper J.B., et al. The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E. coli O157:H7. Environ Microbiol 2009, 11:1815-1826.
35. Xicohtencatl-Cortes J., Monteiro-Neto V., Ledesma M.A., Jordan D.M., Francetic O., Kaper J.B., et al. Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest 2007, 117:3519-3529.
36. Brunder W., Schmidt H., Karch H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 1997, 24:767-778.
37. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
38. Shin R., Suzuki M., Morishita Y. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J Med Microbiol 2002, 51:201-206.
39. Fabich A.J., Jones S.A., Chowdhury F.Z., Cernosek A., Anderson A., Smalley D., et al. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun 2008, 76:1143-1152.
40. Rothe M., Alpert C., Engst W., Musiol S., Loh G., Blaut M. Impact of nutritional factors on the proteome of intestinal Escherichia coli: induction of OxyR-dependent proteins AhpF and Dps by a lactose-rich diet. Appl Environ Microbiol 2012, 78:3580-3591.
41. Alteri C.J., Smith S.N., Mobley H.L. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 2009, 5:e1000448.
42. Genell S., Gustafsson B.E., Ohlsson K. Quantitation of active pancreatic endopeptidases in the intestinal contents of germfree and conventional rats. Scand J Gastroenterol 1976, 11:757-762.
43. Gustafsson B.E. The physiological importance of the colonic microflora. Scand J Gastroenterol Suppl 1982, 77:117-131.
44. Smith E.A., Macfarlane G.T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 1996, 81:288-302.
45. Diaz E., Ferrandez A., Prieto M.A., Garcia J.L. Biodegradation of aromatic compounds by Escherichia coli. Microbiol Mol Biol Rev 2001, 65:523-569.
46. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003, 62:67-72.
47. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
48. Pacheco A.R., Curtis M.M., Ritchie J.M., Munera D., Waldor M.K., Moreira C.G., et al. Fucose sensing regulates bacterial intestinal colonization. Nature 2012, 492:113-117.
49. Kendall M.M., Gruber C.C., Parker C.T., Sperandio V. Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. MBio 2012, 3:50-112.
50. Bommarius B., Anyanful A., Izrayelit Y., Bhatt S., Cartwright E., Wang W., et al. A family of indoles regulate virulence and Shiga toxin production in pathogenic E. coli. PLoS One 2013, 8:e54456.